Lucence Diagnostics, a genomic medicine startup that develops non-invasive tests for cancer screening, announced today that it has raised a $20 million Series A led by IHH Healthcare, one of the world ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Precision oncology company Lucence announced today a partnership with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging ...

PALO ALTO, Calif.--(BUSINESS WIRE)--In partnership with the VA Palo Alto Health Care System, precision oncology company Lucence is launching its first early detection study in the United States ...

SINGAPORE - Local genomic medicine company Lucence announced on Wednesday (Nov 20) that it has received US$20 million (S$27.23 million) in initial funding after it invented a non-invasive test for ...

Lucence Diagnostics, a Singapore-based cancer screening and DNA testing company backed by a private equity unit of sovereign fund Temasek Holdings, is considering setting up a laboratory in Hong Kong ...